Danicjade👤

Core Scientific shareholders rejected a proposed $9B merger with AI firm CoreWeave, citing undervaluation concerns despite potential AI expansion benefits; Core Scientific’s stock rose slightly while CoreWeave’s dipped.

Core Scientific shareholders rejected a proposed $9B merger with AI firm CoreWeave, citing undervaluation concerns despite potential AI expansion benefits; Core Scientific’s stock rose slightly while CoreWeave’s dipped.
decrypt.co •
Revision history

8 recorded changes

Want your article here?

Promote with Leviathan News
Explore the full feed

Comments

Up nextChaos Labs Walks Away From $5M Aave Risk Mandate Over V4 Architecture, Underfunded Risk Budget, And Fundamental Disagreement On How Risk Should Be Managed At DeFi’s Largest Lending Protocol.